UK Markets close in 2 hrs 53 mins
  • FTSE 100

    6,996.02
    +48.03 (+0.69%)
     
  • FTSE 250

    22,229.56
    +62.42 (+0.28%)
     
  • AIM

    1,237.63
    +1.97 (+0.16%)
     
  • GBP/EUR

    1.1662
    +0.0025 (+0.22%)
     
  • GBP/USD

    1.4098
    -0.0045 (-0.3214%)
     
  • BTC-GBP

    39,901.46
    +656.93 (+1.67%)
     
  • CMC Crypto 200

    1,525.09
    +1,282.41 (+528.44%)
     
  • S&P 500

    4,152.10
    -36.33 (-0.87%)
     
  • DOW

    34,269.16
    -473.66 (-1.36%)
     
  • CRUDE OIL

    66.10
    +0.82 (+1.26%)
     
  • GOLD FUTURES

    1,834.40
    -1.70 (-0.09%)
     
  • NIKKEI 225

    28,147.51
    -461.08 (-1.61%)
     
  • HANG SENG

    28,231.04
    +217.23 (+0.78%)
     
  • DAX

    15,182.31
    +62.56 (+0.41%)
     
  • CAC 40

    6,270.37
    +2.98 (+0.05%)
     

Biobanking Market Report 2021-2031

ReportLinker
·5-min read

Forecasts by Biobank Type (Standalone, Partnership), Application (Research, Therapeutics), Sample Type (Bio-fluids, Human Tissue/Tumor Cells, Stem Cells, DNA/RNA, Other Sample Types), Ownership (National/ Regional, Universities, Non-Profit, Private), Region (North America, Europe, Asia Pacific, LAMEA).

New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biobanking Market Report 2021-2031" - https://www.reportlinker.com/p06058467/?utm_source=GNW
PLUS Analysis of Leading Biobanking Companies AND COVID-19 Recovery Scenarios

Within clinical trials and therefore in the fight against COVID-19, biobanks will play an essential role. How can you and your organization be part of this?

The race for a COVID-19 solution is not just a race for profit or market share, but a race to save increased death, and rescue the global economy. Your company needs to be involved today.

What are the Market Opportunities & Threats? This report tells you NOW
• High Potential of Stem Cell Therapeutics in Unmet Clinical Needs
• Importance of Networking & Exchange Between Biobanks
• Growing Demand for Biobanked Samples for Preclinical Research
• Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
• Even with Government Funding, Biobanks Must Become Self Sufficient to Thrive Long-Term
• Public Concerns Over Confidentiality and Security Threaten Availability of Donors

UNIQUE COVID-19 VARIATIONS only available in this this report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.

Which Factors are Fueling Biobanking Industry Growth?
• Rising R&D Expenditure
• Growing Chronic Disease Burden
• Biobanks Are Critical for Cancer Research
• Government Funding to Fuel Market Growth

Which Factors are Restraining Growth?
• Legal & Ethical Challenges in Biobanking
• Lack of Standardization of Approval Required
• Issues in Developing Biobanks & Using Stored Specimens

How do prominent players strengthen their position throughout the world?
You must read this newly updated report if you are involved in this sector. This report shows you potential revenues up to 2031, evaluate information, trends, opportunities and business outlooks. You must read this.

Discover how to stay ahead
Our 360-page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biobanking Market. See how to exploit opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter’s Analysis, product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Biobank Type
• Standalone
• Partnership

Application
• Research
• Therapeutics

Sample Type
• Bio-fluids
• Human Tissue/Tumor Cells
• Stem Cells
• DNA/RNA
• Other Sample Types

Ownership
• National/ Regional
• Universities
• Non-Profit
• Private

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 13 leading national markets:

By Region

• North America:
• U.S.
• Canada

• Europe:
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Denmark
• Finland
• Rest of Europe

• Asia Pacific:
• China
• Japan
• India
• Rest of Asia Pacific

• LAMEA

Leading companies and the potential for market growth
Overall world revenue for Biobanking Market will surpass $xx billion in 2020, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Biobanking Market. Some of the companies profiled in this report include Thermo Fisher Scientific Inc., Merck & Co., QIAGEN, Danaher, STEMCELL Technologies Inc., BioLifeSolutions Inc., BioCision, VWR International, LLC., Hamilton Company, and Becton, Dickinson, and Company (BD).

Key Questions Answered by this Report:
• What is the current size of the overall global Biobanking market? How much will this market be worth from 2021 to 2031?
• What are the main drivers and restraints that will shape the overall biobanking market over the next ten years?
• What are the main segments within the overall Biobanking market? How much will each of these segments be worth for the period 2021 to 2031? How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world Biobanking? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2031?
• How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
• Which are the leading companies and what are their activities, results, developments, and prospects?
• What are the main trends that will affect the world Biobanking market between 2021 and 2031?
• What are the main strengths, weaknesses, opportunities, and threats for the market?
• How will the global Biobanking market evolve over the forecasted period, 2021 to 2031?
• How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. This study is intended for everybody needing commercial analyses for the Global Biobanking Market and leading companies. You will find data, trends and predictions.
Read the full report: https://www.reportlinker.com/p06058467/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001